Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: immunotherapy


False claims of benefit weaken news release on experimental melanoma drug trial


ASCO offers a positive spin on cancer drug survival stats while downplaying severe side effects


‘Eradication of multiple myeloma?’ Phase 2 trials haven’t even started


Association delivers balanced recap of safety trial of targeted immunotherapy for liver cancer


Fred Hutch oversells benefit of new fast-tracked drug for rare skin cancer


Preliminary study gets over-optimistic framing in release on immunotherapy for rheumatoid arthritis patients


Rutgers jumps the gun with news release on Phase 1 immunotherapy trial for thyroid cancer

1 5/24/2016

FDA PR release on bladder cancer drug skirts lack of long-term survival data

1 4/25/2016

Harms, costs and clear benefits omitted from release on anal cancer drug trial

2 5/30/2015

Exemplary Hopkins news release on an early, experimental treatment for multiple myeloma